COVID-19 — Gain-of-Function Research: Definition, History, and the Policy Debate

COVID-19 — Gain-of-Function Research: Definition, History, and the Policy Debate

Overview

Gain-of-function (GOF) research*** is a broad category of life sciences research in which a pathogen is modified to acquire a new or enhanced function — typically increased transmissibility, virulence, or host range. It sits at the intersection of scientific value (pandemic preparedness; vaccine development; understanding viral evolution) and catastrophic risk (accidental release; deliberate misuse). The debate over whether U.S.-funded gain-of-function research at the Wuhan Institute of Virology contributed to the COVID-19 pandemic has been among the most consequential scientific policy debates of the 21st century.

Definitions

The definition of "gain-of-function research" has itself been contested:

• Broad definition***: Any research that increases a pathogen's capability — transmissibility, virulence, or host range
• NIH narrow definition***: Only research specifically designed to enhance pandemic-potential pathogen transmissibility and lethality in humans
• P3CO framework (NIH)***: "Potential Pandemic Pathogen Care and Oversight" — the specific regulatory category introduced in 2017 requiring enhanced review for certain high-risk GOF research

The definitional dispute has been central to the Fauci-Paul congressional exchanges: Paul and Republican investigators used the broader definition; Fauci and NIH used the narrower definitional framework to maintain that NIH-funded WIV research did not qualify as GOF research requiring special review.

The 2014 U.S. Gain-of-Function Research Moratorium

In October 2014, the Obama administration imposed a moratorium on federal funding for new gain-of-function research on influenza, MERS, and SARS pathogens, citing biosafety and biosecurity concerns. The moratorium lasted until December 2017, when the Trump administration lifted it and replaced it with the P3CO framework for enhanced review.

During the moratorium period, some researchers argued that existing ongoing research — including EcoHealth Alliance's WIV collaboration — was not subject to the moratorium because it had been funded before the moratorium or because it did not meet the definition of research that enhanced transmissibility and lethality simultaneously.

Project DEFUSE and the Furin Cleavage Site

The 2018 DARPA DEFUSE grant proposal — rejected by DARPA — specifically proposed inserting furin cleavage sites into bat coronaviruses as part of a pandemic preparedness research program. DARPA's rejection specifically cited GOF concerns. The fact that a proposal to insert furin cleavage sites into bat coronaviruses was submitted in 2018, and that SARS-CoV-2 contains a furin cleavage site not found in closely related viruses, is the most specific circumstantial connection between the GOF debate and the COVID-19 origin question.

Post-COVID Policy Reform

The COVID-19 pandemic generated unprecedented scrutiny of gain-of-function research oversight:

• Congressional investigations found NIH oversight procedures "deficient, unreliable, and a serious threat to public health and national security"
• Multiple bills were introduced to impose new restrictions on GOF research
• International discussions about a global treaty on dangerous pathogen research gained momentum
• EcoHealth Alliance's debarment proceedings represent the most concrete regulatory consequence to date